Treatment planning and skills-assisted exposure with Morpheus

• Conditions: F43.1; Post-traumatic stress disorder

• Registration Number: DRKS00006226
• Lead Sponsor: Zentralinstitut für Seelische Gesundheit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-06-10
• Study Completion: 2016-09-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 98

Inclusion Criteria

Posttraumatic Stress Disorder;

Participation in the inpatient treatment program of dialectical behaviour therapy for Posttraumatic Stress Disorder (DBT-PTSD) at the Central Institute for Mental Health in Mannheim

Exclusion Criteria

Substance abuse

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
PTSD symptomatology is assessed with the Davidson Trauma Scale (DTS) in the (normally weekly) therapy sessions. The inpatient treatment program usually lasts 10-12 weeks.<br><br>After the exposure phase of the treatment, Morpheus will be evaluated with a questionnaire which assesses perceived usefulness of the program as well as patients' satisfaction with Morpheus.<br>

Secondary Outcome Measures

Name	Time	Method
o further outcome measures are used.